OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Systematic review of the clinical effectiveness of Tixagevimab/Cilgavimab for prophylaxis of COVID-19 in immunocompromised patients
Rhea Suribhatla, Thomas Starkey, Maria C. Ionescu, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
Rhea Suribhatla, Thomas Starkey, Maria C. Ionescu, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
Showing 5 citing articles:
Immunocompromised individuals are at increased risk of COVID‐19 breakthrough infection, hospitalization, and death in the post‐vaccination era: A systematic review
Jola Bytyci, Yuxin Ying, Lennard Y. W. Lee
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 4
Open Access | Times Cited: 7
Jola Bytyci, Yuxin Ying, Lennard Y. W. Lee
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 4
Open Access | Times Cited: 7
What is the future for covid drugs and treatments?
Mun-Keat Looi
BMJ (2023), pp. p1001-p1001
Open Access | Times Cited: 9
Mun-Keat Looi
BMJ (2023), pp. p1001-p1001
Open Access | Times Cited: 9
Assessing the post hoc effectiveness of tixagevimab−cilgavimab for prevention of SARS‐CoV‐2 infections in solid organ transplant recipients
Stanley C. Jordan, Sandy Joung, Minhao Wang, et al.
Transplant Infectious Disease (2023) Vol. 26, Iss. 1
Open Access | Times Cited: 5
Stanley C. Jordan, Sandy Joung, Minhao Wang, et al.
Transplant Infectious Disease (2023) Vol. 26, Iss. 1
Open Access | Times Cited: 5
Covid-19: Evusheld protects the most vulnerable patients, analysis shows
Gareth Iacobucci
BMJ (2022), pp. o2690-o2690
Open Access | Times Cited: 6
Gareth Iacobucci
BMJ (2022), pp. o2690-o2690
Open Access | Times Cited: 6
SARS-CoV-2 infection in high-risk children following tixagevimab–cilgavimab (Evusheld) pre-exposure prophylaxis: a single-center observational study
Diego R. Hijano, Jose Ferrolino, Elizabeth Swift, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3
Diego R. Hijano, Jose Ferrolino, Elizabeth Swift, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3
